CervoMed
CRVO
22 hedge funds and large institutions have $5.14M invested in CervoMed in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 8 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
394% more capital invested
Capital invested by funds: $1.04M → $5.14M (+$4.1M)
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
29% more funds holding
Funds holding: 17 → 22 (+5)
0.01% less ownership
Funds ownership: 0.13% → 0.12% (-0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.19M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$236K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$134K |
| 4 |
Jane Street
New York
|
+$93.9K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$87.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$119K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$25K |
| 3 |
Millennium Management
New York
|
-$19K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$9K |
| 5 |
SRCM
Swift Run Capital Management
Charlottesville,
Virginia
|
-$5K |
CRVO Hedge Fund Activity: Q2 2020 in Review
22 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2020, worth a combined $5.14M — up 394% from $1.04M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CRVO positions and 8 closed out — a net gain of 5 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.19M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $119K sold.
- 22 institutional investors held CervoMed (CRVO) as of Q2 2020, up from 17 in Q1 2020.
- Funds reported $5.14M of CervoMed stock for Q2 2020, up 394% quarter-over-quarter.
- 13 funds opened new CervoMed positions in Q2 2020 and 8 closed out, a net change of +5 holders.
- The largest CervoMed buyer in Q2 2020 was Renaissance Technologies, an estimated $1.19M added.
- The largest CervoMed seller in Q2 2020 was Acadian Asset Management, an estimated $119K sold.
Based on aggregated 13F filings for Q2 2020.